PDE11A
From Wikipedia, the free encyclopedia
Phosphodiesterase 11A
|
||||||||||||||
Identifiers | ||||||||||||||
Symbol(s) | PDE11A; FLJ23693; MGC133355; MGC133356 | |||||||||||||
External IDs | OMIM: 604961 MGI: 3036251 HomoloGene: 56763 | |||||||||||||
|
||||||||||||||
RNA expression pattern | ||||||||||||||
Orthologs | ||||||||||||||
Human | Mouse | |||||||||||||
Entrez | 50940 | 241489 | ||||||||||||
Ensembl | ENSG00000128655 | n/a | ||||||||||||
Uniprot | Q9HCR9 | n/a | ||||||||||||
Refseq | NM_001077196 (mRNA) NP_001070664 (protein) |
XM_001002911 (mRNA) XP_001002911 (protein) |
||||||||||||
Location | Chr 2: 178.2 - 178.68 Mb | n/a | ||||||||||||
Pubmed search | [1] | [2] |
Phosphodiesterase 11A, also known as PDE11A, is a human gene.[1]
The 3',5'-cyclic nucleotides cAMP and cGMP function as second messengers in a wide variety of signal transduction pathways. 3',5'-cyclic nucleotide phosphodiesterases (PDEs) catalyze the hydrolysis of cAMP and cGMP to the corresponding 5'-monophosphates and provide a mechanism to downregulate cAMP and cGMP signaling. This gene encodes a member of the PDE protein superfamily. Mutations in this gene are a cause of Cushing disease and adrenocortical hyperplasia. Multiple transcript variants encoding different isoforms have been found for this gene.[1]
[edit] References
[edit] Further reading
- Beavo JA, Conti M, Heaslip RJ (1994). "Multiple cyclic nucleotide phosphodiesterases.". Mol. Pharmacol. 46 (3): 399–405. PMID 7935318.
- "Toward a complete human genome sequence." (1999). Genome Res. 8 (11): 1097–108. PMID 9847074.
- Fawcett L, Baxendale R, Stacey P, et al. (2000). "Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A.". Proc. Natl. Acad. Sci. U.S.A. 97 (7): 3702–7. doi: . PMID 10725373.
- Yuasa K, Kotera J, Fujishige K, et al. (2000). "Isolation and characterization of two novel phosphodiesterase PDE11A variants showing unique structure and tissue-specific expression.". J. Biol. Chem. 275 (40): 31469–79. doi: . PMID 10906126.
- Hetman JM, Robas N, Baxendale R, et al. (2001). "Cloning and characterization of two splice variants of human phosphodiesterase 11A.". Proc. Natl. Acad. Sci. U.S.A. 97 (23): 12891–5. doi: . PMID 11050148.
- Yuasa K, Kanoh Y, Okumura K, Omori K (2001). "Genomic organization of the human phosphodiesterase PDE11A gene. Evolutionary relatedness with other PDEs containing GAF domains.". Eur. J. Biochem. 268 (1): 168–78. PMID 11121118.
- Zauli G, Milani D, Mirandola P, et al. (2001). "HIV-1 Tat protein down-regulates CREB transcription factor expression in PC12 neuronal cells through a phosphatidylinositol 3-kinase/AKT/cyclic nucleoside phosphodiesterase pathway.". FASEB J. 15 (2): 483–91. doi: . PMID 11156964.
- Yuasa K, Ohgaru T, Asahina M, Omori K (2001). "Identification of rat cyclic nucleotide phosphodiesterase 11A (PDE11A): comparison of rat and human PDE11A splicing variants.". Eur. J. Biochem. 268 (16): 4440–8. PMID 11502204.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi: . PMID 12477932.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40–5. doi: . PMID 14702039.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi: . PMID 15489334.
- Weeks JL, Zoraghi R, Beasley A, et al. (2005). "High biochemical selectivity of tadalafil, sildenafil and vardenafil for human phosphodiesterase 5A1 (PDE5) over PDE11A4 suggests the absence of PDE11A4 cross-reaction in patients.". Int. J. Impot. Res. 17 (1): 5–9. doi: . PMID 15538396.
- Loughney K, Taylor J, Florio VA (2005). "3',5'-cyclic nucleotide phosphodiesterase 11A: localization in human tissues.". Int. J. Impot. Res. 17 (4): 320–5. doi: . PMID 15800651.
- Wayman C, Phillips S, Lunny C, et al. (2005). "Phosphodiesterase 11 (PDE11) regulation of spermatozoa physiology.". Int. J. Impot. Res. 17 (3): 216–23. doi: . PMID 15800654.
- Hillier LW, Graves TA, Fulton RS, et al. (2005). "Generation and annotation of the DNA sequences of human chromosomes 2 and 4.". Nature 434 (7034): 724–31. doi: . PMID 15815621.
- D'Andrea MR, Qiu Y, Haynes-Johnson D, et al. (2005). "Expression of PDE11A in normal and malignant human tissues.". J. Histochem. Cytochem. 53 (7): 895–903. doi: . PMID 15995148.
- Francis SH (2005). "Phosphodiesterase 11 (PDE11): is it a player in human testicular function?". Int. J. Impot. Res. 17 (5): 467–8. doi: . PMID 16079899.
- Gross-Langenhoff M, Hofbauer K, Weber J, et al. (2006). "cAMP is a ligand for the tandem GAF domain of human phosphodiesterase 10 and cGMP for the tandem GAF domain of phosphodiesterase 11.". J. Biol. Chem. 281 (5): 2841–6. doi: . PMID 16330539.
- Horvath A, Boikos S, Giatzakis C, et al. (2006). "A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia.". Nat. Genet. 38 (7): 794–800. doi: . PMID 16767104.
- Wong ML, Whelan F, Deloukas P, et al. (2006). "Phosphodiesterase genes are associated with susceptibility to major depression and antidepressant treatment response.". Proc. Natl. Acad. Sci. U.S.A. 103 (41): 15124–9. doi: . PMID 17008408.